NET PROFIT (x1000 NOK)
EMPLOYEES
QuiaPEG Pharmaceuticals AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
34
|
25
|
52 |
| Earnings before taxes |
-10,258
|
-13,183
|
-12,828 |
| EBITDA |
-6,150
|
-9,248
|
-9,590 |
| Total assets |
17,530
|
21,209
|
20,354 |
| Current assets |
304
|
751
|
1,739 |
| Current liabilities |
4,734
|
4,843
|
14,864 |
| Equity capital |
12,796
|
16,366
|
5,437 |
| - share capital |
159
|
156
|
146 |
| Employees (average) |
2
|
3
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.0%
|
77.2%
|
26.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-58.3%
|
-62.0%
|
-62.8% |
| Current ratio |
6.4%
|
15.5%
|
11.7% |
| Return on equity (ROE) |
-80.2%
|
-80.6%
|
-235.9% |
| Change turnover |
0
|
0
|
-204 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
-1
|
-1 |
| Chg. No. of employees % |
-33%
|
-25%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.